Literature DB >> 32012473

Impact of scoliosis surgery on pulmonary function in patients with muscular dystrophies and spinal muscular atrophy.

Harold J Farber1, William A Phillips2, Kenneth L Kocab3, Darrell S Hanson4, John A Heydemann2, Benny T Dahl2, Elizabeth T Spoede5, Larry S Jefferson1.   

Abstract

BACKGROUND: Scoliosis is a common complication of severe neuromuscular diseases. The aim of this study is to determine the impact of posterior spinal fusion on pulmonary function parameters in patients with severe neuromuscular disease at our medical center.
METHODS: Retrospective chart review of all patients with severe neuromuscular disease who had posterior spinal fusion between 2012 and 2017 at Texas Children's Hospital. Patients with growing rods, brain injury or malformation, and/or spina bifida were excluded. Pulmonary function measures before and after spinal surgery were determined.
RESULTS: A total of 20 eligible patients were identified, 7 with Duchenne muscular dystrophy, 6 with spinal muscular atrophy, 3 with merosin deficient muscular dystrophy, 2 with Charcot-Marie-Tooth, 1 with central core disease, and 1 with dystroglycanopathy. The mean change in vital capacity from pre- to postspine surgery was a loss of 0.63 L for the spinal muscular atrophy patients, a loss of 0.36 L for the Duchenne muscular dystrophy patients, and a gain of 0.23 L for the merosin deficient patients. The difference between spinal muscular atrophy and merosin deficient patients was statistically significant (P = .02)
CONCLUSION: In this single-center retrospective study, we found that after spine surgery for scoliosis, all patients with spinal muscular atrophy and most patients with Duchenne muscular dystrophy lost vital capacity, while the patients with merosin deficient muscular dystrophy gained vital capacity. These differences were not associated with differences is respiratory strength, body mass index, or surgical outcomes.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  neuromuscular disorders; pulmonary function testing (PFT)

Mesh:

Year:  2020        PMID: 32012473     DOI: 10.1002/ppul.24664

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  5 in total

Review 1.  The effect of scoliosis surgery on pulmonary function in spinal muscular atrophy patients: review of the literature and a meta-analysis.

Authors:  Maria Angeli; Kalliopi Alpantaki; Nikolaos Pandis; Christos Koutserimpas; Alexander Hadjipavlou
Journal:  Eur Spine J       Date:  2022-06-04       Impact factor: 2.721

2.  Scoliosis Orthopedic Surgery Combined With Nusinersen Intrathecal Injection Significantly Improved the Outcome of Spinal Muscular Atrophy Patient: A Case Report.

Authors:  Beiyu Xu; Cuijie Wei; Xiao Hu; Wenzhu Li; Zhen Huang; Chengli Que; Jianxing Qiu; Chunde Li; Hui Xiong
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.086

3.  Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study.

Authors:  Federica Trucco; Deborah Ridout; Mariacristina Scoto; Giorgia Coratti; Marion L Main; Robert Muni Lofra; Anna G Mayhew; Jacqueline Montes; Marika Pane; Valeria Sansone; Emilio Albamonte; Adele D'Amico; Enrico Bertini; Sonia Messina; Claudio Bruno; Deepak Parasuraman; Anne-Marie Childs; Vasantha Gowda; Tracey Willis; Min Ong; Chiara Marini-Bettolo; Darryl C De Vivo; Basil T Darras; John Day; Elizabeth A Kichula; Oscar H Mayer; Aledie A Navas Nazario; Richard S Finkel; Eugenio Mercuri; Francesco Muntoni
Journal:  Neurology       Date:  2020-10-16       Impact factor: 9.910

4.  Clinical Issues in Indication, Correction, and Outcomes of the Surgery for Neuromuscular Scoliosis: Narrative Review in Pedicle Screw Era.

Authors:  Hak Sun Kim; Ji Won Kwon; Kun-Bo Park
Journal:  Neurospine       Date:  2022-01-29

5.  Short-term effect and effect on rate of lung function decline after surgery for neuromuscular or syndromic scoliosis.

Authors:  Esther S Veldhoen; Anneloes de Vries; Tom P C Schlosser; Moyo C Kruyt; Ruben P A van Eijk; Joyce M Tersmette; Erik H Hulzebos; Ludo W van der Pol; Roelie M Wösten-van Asperen; Cornelis K van der Ent
Journal:  Pediatr Pulmonol       Date:  2022-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.